Keywords: TINs; tumor-infiltrating neutrophils; TILs; tumor-infiltrating lymphocytes; NLR; neutrophil/lymphocyte rate; BC; bladder cancer; IHC; immunohistochemistry; OS; overall survival; NMIBC; non-muscle invasive bladder cancer; MIBC; muscle invasive bladder canc
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: urinary bladder neoplasms; cystectomy; time-to-treatment; quality improvement; EMR; electronic medical record; NAC; neoadjuvant chemotherapy; RC; radical cystectomy; TURBT; transurethral resection of bladder tumor;
Keywords: CIS; carcinoma in situ; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle-invasive bladder cancer; RC; radical cystectomy; TURBT; transurethral resection of bladder tumour; Bladder cancer; TURBT; T1G3;
Keywords: Complication; Pathology; Thulium laser; Tumor stage; TURBT;
Keywords: ACS-NSQIP; Cystectomy; Nephrectomy; Prostatectomy; TURBT;
Keywords: urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: urinary bladder neoplasms; administration; intravesical; BCG vaccine; mitomycin; interferons; BCG; bacillus Calmette-Guérin; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; SOE; strength of evidence; TURBT; transurethral bladder tumor resecti
Keywords: fluorescence; cystoscopy; aminolevulinic acid; urinary bladder neoplasms; 5-ALA; 5-aminolevulinic acid; HAL; hexaminolevulinic acid; NMIBC; nonmuscle invasive bladder cancer; RCT; randomized, controlled trial; SOE; strength of evidence; TURBT; transurethr
Keywords: bladder neoplasms; risk assessment; practice guidelines as topic; mortality; BCG vaccine; BCG; bacillus Calmette-Guérin; CUETO; Club Urológico Español de Tratamiento Oncológico; EORTC; European Organization for Research and Treatment of Cancer; NCCN®
Keywords: urology; women; surgeons; practice patterns; physician's; socioeconomic factors; ESWL; extracorporeal shock wave lithotripsy; FPMRS; female pelvic medicine and reconstructive surgery; Nx; nephrectomy; TURBT; transurethral resection of bladder tumor; URS;
Keywords: urinary bladder neoplasms; biopsy; neoplasm recurrence; local; cystoscopy; cytology; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CT; computerized tomography; PFS; progression-free survival; RFS; recurrence-free survival; TURBT; transurethral r
Keywords: urinary bladder neoplasms; prostatic hyperplasia; transurethral resection of prostate; time factors; time-to-treatment; AMC; Albany Medical Center; ASA®; American Society of Anesthesiologists; KGH; Kingston General Hospital; TURBT; transurethral bladder
Keywords: urinary bladder neoplasms; cautery; artifacts; obturator nerve; intraoperative complications; CONSORT; Consolidated Standards of Reporting Trials; TUR; transurethral resection; TURBT; bladder tumor TUR;
Keywords: incidence; urinary bladder neoplasms; neoplasm staging; Spain; BC; bladder cancer; BCG; bacillus Calmette-Guérin; BMI; body mass index; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor
Keywords: urinary bladder; carcinoma; papillary; evidence-based practice; practice guideline; risk; AUA; American Urological Association; CIS; carcinoma in situ; CTU; computerized tomography urogram; EAU; European Association of Urology; ICUD; International Consult
Keywords: urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; risk; AUA; American Urological Association; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Club Urologico Espanol de Tratamiento Oncologi
Keywords: urinary bladder neoplasms; neoplasm metastasis; lymph nodes; genomics; biomarkers, tumorFFPE, formalin fixed, paraffin embedded; LN, lymph node; MIBC, muscle invasive bladder cancer; NAC, neoadjuvant chemotherapy; PLND, pelvic lymph node dissection; TURBT
Overexpression of COX2 indicates poor survival in urothelial bladder cancer
Keywords: COX2; cyclo-oxygenase 2; NMIUC; Non-muscle invasive urothelial carcinoma; MIUC; muscle invasive urothelial carcinoma; TURBT; Transurethral resection of bladder tumor; BCG; Bacillus Calmette Guerin; TIL; Tumor infiltrating lymphocytes; NK; Natural Killer;
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy
Keywords: urinary bladder neoplasms; M-VAC protocol; gemcitabine; cisplatin; mortality; aMVAC; accelerated MVAC; CSS; cancer specific survival; ddMVAC; dose dense MVAC; GC; gemcitabine and cisplatin; LVI; lymph node invasion; MVAC; methotrexate, vinblastine, doxoru
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database
Keywords: urinary bladder neoplasms; aged; chemoradiotherapy; cystectomy; mortality; CCI; Charlson-Deyo comorbidity index; CRT; chemoradiation therapy; MIBC; muscle invasive bladder cancer; NCDB; National Cancer Database; OS; overall survival; RC; radical cystectom
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term Followup
Keywords: urinary bladder neoplasms; neoadjuvant therapy; drug therapy; survival; CSS; cancer specific survival; MFS; metastasis-free survival; MIBC; muscle invasive urothelial carcinoma of the bladder; NAC; neoadjuvant chemotherapy; OS; overall survival; RC; radic
NSQIP® Indexed Complications Following Transurethral Bladder Tumor Resection and Contemporary Financial Implications
Keywords: urologic neoplasms; urinary bladder neoplasms; ALOS; average length of stay; DRG; Diagnosis Related Group; LOS; postoperative length of stay; NSQIP; National Surgical Quality Improvement Project; RVU; relative value unit; TURBT; transurethral bladder tumo
Exploring Patterns of Mitomycin C Use in Community Practice Urology
Keywords: urinary bladder neoplasms; endoscopy; mitomycin; community health services; quality improvement; CCI; Charlson comorbidity index; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor resection;
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
Keywords: urinary bladder neoplasms; neoplasm invasiveness; watchful waiting; risk; cost-benefit analysis; AS; active surveillance; IOF; in-office fulguration; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; TUR; transurethral resection; TURBT;
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
Keywords: urinary bladder neoplasms; BCG vaccine; adjuvants; immunologic; skin tests; adverse effects; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; LUTS; lower urinary tract symptoms; NMIBC; nonmuscle invasive bladder cancer; PFS; progression-free surviv
Mini-ReviewSimulators in the urological training armamentarium: A boon or a bane?
Keywords: TURBT; transurethral resection of bladder tumour; URS; ureterorenoscopy; VR; virtual reality; Simulators; Urology; Training; Medical simulators;
OncologyMetastatic Melanoma to the Bladder: Case Report and Review of the Literature
Keywords: Bladder; Melanoma; Cystectomy; Metastatic; CT; computed tomography; MRI; magnetic resonance imaging; TURBT; transurethral resection of bladder tumor; TUR; transurethral resection; SBRT; stereotactic body radiation therapy;
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Keywords: urinary bladder neoplasms; radiotherapy; cystectomy; drug therapy; AC; adjuvant chemotherapy; AHRQ; Agency for Healthcare Research and Quality; ASCO; American Society of Clinical Oncology; ASTRO; American Society for Radiation Oncology; AUA; American Uro
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Keywords: Bladder cancer; Radical cystectomy; TURBT; Neoadjuvant chemotherapy;
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer
Keywords: Bladder cancer; En bloc; TURBT; Laser; Urothelial carcinoma;
Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
Keywords: urinary bladder neoplasms; Mycobacterium bovis; mitomycin; drug delivery systems; treatment outcome; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; EMDA; electromotive drug administration; HR; high risk; MIBC; muscle invasive bladder cancer; MMC;
Take a Number? Surgical Waiting Times for Transurethral Bladder and Prostate Surgery in Albany, New York
Keywords: time factors; time-to-treatment; urinary bladder neoplasms; prostatic hyperplasia; carcinoma; transitional cell; ASA®; American Society of Anesthesiologists; LUTS; lower urinary tract symptoms; TURBT; transurethral bladder tumor resection; TURP; transure
Transurethral Bladder Tumor Resection Can Cause Seeding of Cancer Cells into the Bloodstream
Keywords: urinary bladder neoplasms; neoplastic cells; circulating; neoplasm metastasis; CTC; circulating tumor cell; CV; central vein; IVC; inferior vena cava; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle invasive bladder cancer; PV; peripheral vein; TUR
The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: An analysis of ACS NSQIP data
Keywords: Bladder cancer; TURBT; Complications; Outcomes;
Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma
Keywords: ZNF165; zinc finger protein 165; TCC; transitional cell carcinoma; CTA; cancer testis antigen; qRTPCR; quantitative real-time PCR; IHC; immunohistochemistry; TURBT; transurethral resection of bladder tumor; WHO; World Health Organization; BCG; bacillus Ca
Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
Keywords: urinary bladder neoplasms; carcinoma; transitional cell; cystectomy; outcome assessment (health care); pathology; surgical; CIS; carcinoma in situ; DSS; disease specific survival; LN; lymph node; LVI; lymphovascular invasion; NV; nonvariant; OS; overall s
Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence
Keywords: Urothelial carcinoma; Lamina propria; TURBT; Resection; Recurrence; pT1
Comparison of Perioperative Outcomes including Severe Bladder Injury between Monopolar and Bipolar Transurethral Resection of Bladder Tumors: A Population Based Comparison
Keywords: electrocoagulation; outcome assessment; postoperative complications; urinary bladder neoplasms; B-TURBT; bipolar transurethral bladder tumor resection; CCI; Charlson comorbidity index; DPC; Diagnosis Procedure Combination; M-TURBT; monopolar transurethral
Hydrostatic pressure enhances mitomycin C induced apoptosis in urothelial carcinoma cells
Keywords: UC; urothelial carcinoma; MMC; mitomycin C; TURBT; transurethral resection of the bladder tumor; BCG; Bacillus Calmette-Guerin; RT-PCR; reverse transcription-PCR; qRT-PCR; quantitation RT-PCR; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom
Epigenetic Inactivation of KLF4 is Associated with Urothelial Cancer Progression and Early Recurrence
Keywords: urinary bladder; urothelium; carcinoma; genes; tumor suppressor; mortality; 5-AZA-dc; 5-aza-2-deoxycytidine; EMT; epithelial-to-mesenchymal transition; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; KLF4; Krüppel-like factor 4; NMIBC; nonmuscle invasiv
Resection of Ureteral Orifice During Transurethral Resection of Bladder Tumor: Functional and Oncologic Implications
Keywords: urinary bladder; urinary bladder neoplasms; ureteral obstruction; neoplasm recurrence, local; hydronephrosis; TURBT; transurethral resection of bladder tumor;
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
Keywords: apaziquone; urinary bladder neoplasms; drug therapy; administration; intravesical; AE; adverse event; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bla
Economic and Humanistic Consequences of Preventable Bladder Tumor Recurrences in Nonmuscle Invasive Bladder Cancer Cases
Keywords: urinary bladder neoplasms; administration, intravesical; mitomycin; economics, pharmaceutical; quality-adjusted life years; BCG; bacillus Calmette-Guérin; IVIC; intravesical instillation of chemotherapy; MMC; mitomycin C; NMIBC; nonmuscle invasive bladde
Understanding the Use of Immediate Intravesical Chemotherapy for Patients with Bladder Cancer
Keywords: urinary bladder neoplasms; administration; intravesical; drug therapy; quality improvement; IRB; institutional review board; IVC; intravesical chemotherapy; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bladder tumor; USQC; U
National Practice Patterns for Immediate Postoperative Instillation of Chemotherapy in Nonmuscle Invasive Bladder Cancer
Keywords: urinary bladder neoplasms; drug therapy; administration, intravesical; physician's practice patterns; urology; AUA; American Urological Association; CIS; carcinoma in situ; IPOC; intravesical postoperative chemotherapy; IPOIC; immediate postoperative inst
Selective organ preservation in muscle-invasive bladder cancer: Review of the literature
Keywords: TURBT; Radiochemotherapy; Cisplatin; Radical cystectomy; T2–T3
Management of pT1G3 Bladder Cancer
Keywords: Non muscle invasive bladder cancer; TURBT; BCG; Cystectomy
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α
Keywords: urinary bladder; urinary bladder neoplasms; BCG vaccine; interferon alfa-2b; prognosis; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Spanish Urological Club for Oncological Treatment; EORTC; European Organization for Research and Treatme